SINOPHARM TECH: DESPATCH OF CIRCULAR IN RELATION TO (1)PROPOSED CAPITAL REORGANISATION; (2)CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE; (3)APPLICATION FOR WHITEWASH WAIVE
SINOPHARM TECH: (1)PROPOSED CAPITAL REORGANISATION;(2)CONNECTED TRANSACTIONS:LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE;(3)APPLICATION FOR WHITEWASH WAIVER;(4)LOAN CAPITALISATION INVOLVING ISSU
SINOPHARM TECH: CLOSURE OF REGISTER OF MEMBERS FOR EXTRAORDINARY GENERAL MEETING
SINOPHARM TECH: (1) PROPOSED CAPITAL REORGANISATION;(2) CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE;(3) APPLICATION FOR WHITEWASH WAIVER;(4) LOAN CAPITALISATION INVOLV
SINOPHARM TECH: INSIDE INFORMATION WITHDRAWAL OF WINDING-UP PETITION
SINOPHARM TECH: INSIDE INFORMATION FURTHER ADJOURNMENT OF WINDING-UP PETITION HEARING
SINOPHARM TECH: INSIDE INFORMATION FURTHER ADJOURNMENT OF WINDING-UP PETITION HEARING
SINOPHARM TECH: INSIDE INFORMATION - ADJOURNMENT OF WINDING-UP PETITION HEARING
SINOPHARM TECH: INSIDE INFORMATION WINDING UP PETITION
SINOPHARM TECH: CLARIFICATION ANNOUNCEMENT IN RESPECT OF THE CIRCULAR DATED 10 AUGUST 2023
SINOPHARM TECH: PROPOSED SHARE CONSOLIDATION,PROPOSED CHANGE IN BOARD LOT SIZEANDNOTICE OF EXTRAORDINARY GENERAL MEETING
SINOPHARM TECH: PROPOSED SHARE CONSOLIDATION AND PROPOSED CHANGE IN BOARD LOT SIZE
SINOPHARM TECH: GRANT OF SHARE OPTIONS
SINOPHARM TECH: CONNECTED TRANSACTIONLOAN CAPITALISATION INVOLVING ISSUE OFNEW SHARES UNDER SPECIFIC MANDATEANDNOTICE OF EXTRAORDINARY GENERAL MEETING
SINOPHARM TECH: FURTHER DELAY IN DESPATCH OF CIRCULAR
SINOPHARM TECH: DELAY IN DESPATCH OF CIRCULAR
SINOPHARM TECH: UPDATE ON THE PROFIT GUARANTEE IN RELATION TO THE ACQUISITION OF THE TARGET COMPANY INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE
SINOPHARM TECH: CONNECTED TRANSACTION LOAN CAPITALISATION INVOLVING ISSUE OF NEW SHARES UNDER SPECIFIC MANDATE
SINOPHARM TECH: PROFIT GUARANTEE IN RELATION TO THE ACQUISITION OF THE TARGET COMPANY INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE
SINOPHARM TECH: LAPSE OF THE ISSUE OF CONVERTIBLE BONDS UNDER THE SECOND SUBSCRIPTION AGREEMENT
No Data